Diverging Pediatric Recommendations on COVID-19 Vaccination: The AAP Advocates Routine Immunization for Young Children Amid Federal Policy Shift
Posted inAllergy & Immunology Infectious Diseases Pediatrics Public Health Specialties

Diverging Pediatric Recommendations on COVID-19 Vaccination: The AAP Advocates Routine Immunization for Young Children Amid Federal Policy Shift

The American Academy of Pediatrics recommends COVID-19 vaccination for all young children aged 6-23 months, diverging from current CDC policies that advise shared decision-making for healthy children. This review analyzes epidemiologic data, guideline conflicts, and implications for pediatric COVID-19 vaccine policies.
Prenatal Exposure to Chlorpyrifos and Its Long-Term Impact on Brain Development and Motor Function in Children: Evidence from Imaging and Cohort Studies
Posted inClinical Updates Neurology news OB/GYN & Women's Health Pediatrics Specialties

Prenatal Exposure to Chlorpyrifos and Its Long-Term Impact on Brain Development and Motor Function in Children: Evidence from Imaging and Cohort Studies

Elevated prenatal chlorpyrifos exposure is linked to widespread brain structural abnormalities, reduced neuronal density, and impaired motor functions in children, underscoring the need for exposure minimization during pregnancy.
Posted inClinical Updates Family Medicine & Nutrition Neurology news Pediatrics Specialties

Ketogenic Diet vs Further Antiseizure Medication in Infants with Drug-Resistant Epilepsy: What the KIWE Trial Adds to Clinical Practice

The KIWE randomised trial (Lancet Neurol 2023) found no superiority of a classic ketogenic diet over an additional antiseizure medication for seizure frequency in infants (1–24 months) with drug‑resistant epilepsy; tolerability and safety profiles were similar, supporting the diet as a viable treatment option.